Pangyo, Gyeonggi, 16 Oct, 2017| Institut Pasteur Korea (IPK, CEO: Dr. Wang-Shick Ryu) announce the 2017 Open House will be held on 31 Oct at the IPK auditorium.

The 2017 Open House will showcase IPK’s role in the convergence of knowledge and technology. IPK will share its drug discovery technology and best practices for commercialization with Qurient. And WuXi AppTec, Chinese bio tech, will hold a research seminar on Biomedicine research and IND service.

For more information on 2017 Open House, see below:

2017 Open House
Time: 31 Oct, 2017/14:30 PM ~,
Venue: 1st floor Auditorium at Institut Pasteur Korea
          (16 Daewangpangyo-ro 712 beon-gil, Bundang-gu, Seongnam-si, Gyeonggi)
Contact: IPK (031-8018-8031~2 | RTV-DIV@ip-korea.org)
            Wuxi AppTec (031-724-2864 | michael_wang@wuxiapptec.com)
Online Registration: https://goo.gl/forms/13KZ2VeAgVf1BAOr1

#  #  #  #  #  #

About Institut Pasteur Korea
Institut Pasteur Korea (IPK) is an international research institute focused on addressing global health issues with a combination of cutting edge approaches in order to understand disease mechanisms and develop new treatments. By promoting multi-disciplinary projects, IPK is at the forefront of drug discovery and an economic growth engine that contributes to Korea's scientific intellectual and technical resources. IPK has four core missions of public interest; 1) Research, combining front line biology, IT, and chemistry, with innovative cell-based drug discovery platforms that identify novel molecular targets for potential new therapies to treat diseases, 2) Education, offering a wide range of programming to nurture the development of the next generation of scientists and health professionals, 3) Public Health, working in collaboration with national and international health authorities, and 4) Translation of biomedical discoveries to improve health via technology transfer and industrial partnerships.
 
IPK is a member of the Institut Pasteur International Network (Network). As a hub institution, IPK plays a key role in the Network, serving as a bridge between Korea and global bio-pharma science, expanding Korea's R&D base collaborative research projects with global alliances
 
The institute was established in April 2004 in collaboration with Institut Pasteur Paris and the Korea Institute of Science and Technology (KIST), with support from the Ministry of Science, ICT and Future Planning (MSIP). IPK also has a great supporter in the Gyeonggi Provincial government (2005 – 2015 : Block funding | 2016 – Present : drug discovery co-resarch fund for pharm industries).